| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |